— Know what they know.
Not Investment Advice

MA vs V vs AXP

161 measures in 16 categories, one definition each, computed from filings and market data.
MA77.4
Mastercard Incorporated
Financial Services · Financial - Credit Services
$617.42 +0.17%$540.9B mkt cap
Score DNA
V73.5
Visa Inc.
Financial Services · Financial - Credit Services
$402.61 +0.72%$751.7B mkt cap
Score DNA
AXP56.0
American Express Company
Financial Services · Financial - Credit Services
$313.59 −0.09%$211.8B mkt cap
Score DNA

Price, rebased to 100 three years ago

MA   V   AXP   · weekly adjusted closes
100150200250Jan 24Apr 24Jul 24Oct 24Jan 25Apr 25Jul 25Oct 25Jan 26Apr 26Jul 26Oct 26AXP 212V 172MA 157
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.

Smart money

8 measures
MeasureMAVAXP
Insider open-market buys, 180d 0 0 0
Insider $ bought, 180d — — —
Congress purchases, 180d 14 5 5
Last Congress purchase 2026-06-29 2026-09-25 2026-09-15
13F net change in holders +9 +110 +114
ETFs adding shares, 30d 1,764 1,988 1,395
ETFs trimming, 30d 1,442 1,432 1,289
Net ETF funds, 30d +322 +556 +106

Valuation

16 measures
MeasureMAVAXP
P/E (TTM) 33.3x
94th
33.3x
97th
18.5x
76th
PEG (P/E ÷ 3-yr EPS CAGR) 1.70
92nd
2.43
96th
0.98
68th
Price / sales 15.4x
98th
16.9x
100th
2.5x
86th
Price / book 96.4x
100th
21.4x
98th
6.2x
93rd
Price / tangible book — — 6.7x
92nd
Price / free cash flow n/a n/a n/a
Price / operating cash flow n/a n/a n/a
Enterprise value n/a n/a n/a
EV / sales n/a n/a n/a
EV / EBITDA n/a n/a n/a
EV / EBIT n/a n/a n/a
EV / free cash flow n/a n/a n/a
Earnings yield 3.0%
24th
3.0%
21st
5.4%
38th
FCF yield n/a n/a n/a
Operating cash flow yield n/a n/a n/a
Graham number (per share) $51.31
35th
$69.18
47th
$138.58
82nd

Profitability (TTM)

12 measures
MeasureMAVAXP
Gross margin n/a n/a n/a
EBITDA margin n/a n/a n/a
Operating margin 59.9%
93rd
60.7%
95th
27.2%
67th
EBIT margin 58.9%
98th
62.4%
100th
27.2%
76th
Net margin 46.3%
98th
50.8%
100th
13.6%
62nd
NOPAT margin 48.3%
90th
50.9%
93rd
21.1%
62nd
FCF margin n/a n/a n/a
Operating cash flow margin n/a n/a n/a
R&D / revenue 0.0%
0th
0.0%
0th
0.0%
0th
SG&A / revenue 32.8%
81st
11.6%
31st
29.8%
74th
Stock comp / revenue 1.4%
67th
2.1%
79th
0.7%
43rd
Effective tax rate 19.4%
20th
16.2%
8th
22.5%
57th

Returns on capital

11 measures
MeasureMAVAXP
ROE (on average equity) 241.1%
100th
61.2%
93rd
34.4%
81st
ROA 29.8%
98th
23.2%
95th
3.8%
64th
ROIC n/a n/a n/a
ROCE n/a n/a n/a
Return on tangible assets 37.9%
98th
28.5%
95th
7.6%
67th
Cash ROIC (OCF / invested capital) n/a n/a n/a
Gross profitability (GP / assets) n/a n/a n/a
ROIC, 3-yr average n/a n/a n/a
ROIC, 5-yr average n/a n/a n/a
ROE, 5-yr average 194.1%
100th
49.7%
94th
31.7%
92nd
Incremental ROIC n/a n/a n/a

Growth

17 measures
MeasureMAVAXP
Revenue growth (TTM YoY) 16.0%
59th
14.4%
54th
9.4%
44th
Revenue growth (QoQ) 10.5%
86th
3.6%
67th
3.4%
64th
Revenue CAGR, 3 yr 14.1%
62nd
11.8%
57th
10.7%
54th
Revenue CAGR, 5 yr 16.1%
63rd
14.5%
60th
16.2%
66th
Gross profit CAGR, 3 yr n/a n/a n/a
Operating income CAGR, 3 yr 17.1%
41st
9.5%
31st
35.3%
78th
Net income growth (TTM YoY) 19.7%
48th
11.4%
30th
12.8%
33rd
Net income CAGR, 3 yr 16.7%
62nd
11.0%
35th
15.4%
58th
EPS growth (TTM YoY) 23.2%
44th
12.9%
26th
16.3%
33rd
EPS CAGR, 3 yr 19.5%
62nd
13.7%
46th
18.9%
58th
EPS CAGR, 5 yr 20.5%
92nd
18.6%
88th
14.0%
85th
FCF growth (TTM YoY) n/a n/a n/a
FCF CAGR, 3 yr n/a n/a n/a
Operating cash flow CAGR, 3 yr n/a n/a n/a
Book value CAGR, 3 yr 3.1%
25th
-1.0%
11th
11.9%
64th
Dividend CAGR, 3 yr 6.4%
74th
5.9%
65th
7.5%
83rd
Sustainable growth rate 197.8%
100th
47.7%
91st
27.1%
76th

Margin history & stability

7 measures
MeasureMAVAXP
Gross margin, 3-yr average n/a n/a n/a
Operating margin, 3-yr average 57.3%
95th
62.7%
97th
20.5%
59th
Net margin, 3-yr average 45.9%
97th
52.6%
100th
13.5%
59th
FCF margin, 3-yr average n/a n/a n/a
Revenue stability (0-1) 0.99
92nd
0.99
97th
0.98
82nd
Earnings stability (0-1) 0.98
95th
0.98
97th
0.91
74th
Margin stability (0-1) 0.90
74th
0.99
100th
0.92
90th

Liquidity (latest quarter)

7 measures
MeasureMAVAXP
Cash & short-term investments n/a n/a n/a
Net cash (− = net debt) n/a n/a n/a
Working capital n/a n/a n/a
Current ratio n/a n/a n/a
Quick ratio n/a n/a n/a
Cash ratio (cash + ST investments / current liabilities) n/a n/a n/a
Defensive interval (days) n/a n/a n/a

Leverage & solvency (latest quarter)

13 measures
MeasureMAVAXP
Total debt n/a n/a n/a
Debt / equity n/a n/a n/a
Net debt / equity n/a n/a n/a
Debt / assets n/a n/a n/a
Debt / capital n/a n/a n/a
Debt / EBITDA n/a n/a n/a
Net debt / EBITDA n/a n/a n/a
Interest coverage (EBIT / interest) n/a n/a n/a
Cash interest coverage n/a n/a n/a
Debt payback (years of OCF) n/a n/a n/a
Liabilities / assets 90.3%
83rd
62.8%
17th
88.9%
71st
IS credit model rating AA AA+ AA
Implied credit spread (bps) 80
17th
65
2nd
80
17th

Efficiency

11 measures
MeasureMAVAXP
Asset turnover n/a n/a n/a
Fixed asset turnover n/a n/a n/a
Inventory turnover n/a n/a n/a
Receivables turnover n/a n/a n/a
Days sales outstanding n/a n/a n/a
Days inventory outstanding n/a n/a n/a
Days payables outstanding n/a n/a n/a
Cash conversion cycle (days) n/a n/a n/a
Capex / revenue n/a n/a n/a
Capex / depreciation n/a n/a n/a
Operating expense ratio n/a n/a n/a

Cash flow & earnings quality

7 measures
MeasureMAVAXP
Operating cash flow / net income n/a n/a n/a
FCF / net income n/a n/a n/a
FCF / operating cash flow n/a n/a n/a
Capex / operating cash flow n/a n/a n/a
Accruals ratio n/a n/a n/a
Sloan accruals ratio n/a n/a n/a
Earnings quality score (0-1) n/a n/a n/a

Dividends & buybacks

9 measures
MeasureMAVAXP
Dividend yield 0.6%
48th
0.7%
50th
1.2%
62nd
Dividend per share (TTM) $3.48
90th
$2.68
86th
$3.67
93rd
Payout ratio (dividends / net income) 18.0%
62nd
22.1%
71st
21.1%
68th
Dividends / FCF n/a n/a n/a
Dividend growth (YoY) 15.5%
80th
11.8%
72nd
17.1%
88th
Buyback yield 1.4%
33rd
2.8%
55th
3.5%
60th
Shareholder yield (dividends + buybacks) 2.0%
24th
3.5%
50th
4.7%
57th
Share count change (YoY) -2.9%
41st
-1.3%
51st
-3.0%
38th
Buybacks, last 5 years $31.0B
95th
$87.0B
100th
$31.3B
98th

Scores & forensic checks

15 measures
MeasureMAVAXP
IS score 77
95th
73
93rd
56
55th
IS profitability 100
95th
100
95th
75
81st
IS growth 89
100th
65
62nd
58
41st
IS value 44
24th
38
10th
50
31st
IS momentum 86
69th
77
51st
83
59th
IS risk (safety) 100
45th
100
45th
100
45th
IS quality 67
74th
81
95th
80
90th
IS balance sheet 58
81st
71
93rd
50
62nd
IS earnings quality 76
81st
85
93rd
70
57th
IS cash flow 76
64th
76
57th
74
50th
Piotroski F-score (0-9) 7
45th
5
19th
9
95th
Altman Z-score — — —
Beneish M-score — — —
Ohlson O-score −7.25
26th
−9.02
5th
−7.37
24th
IS credit score 87
67th
92
93rd
89
83rd

Per share

7 measures
MeasureMAVAXP
EPS, diluted (TTM) $18.41
93rd
$11.69
76th
$16.88
88th
Book value per share $6.35
7th
$18.20
37th
$50.56
73rd
Tangible book per share −$10.61
2nd
−$6.89
7th
$50.56
81st
Revenue per share $39.73
49th
$23.02
32nd
$124.00
88th
FCF per share n/a n/a n/a
Operating cash flow per share n/a n/a n/a
Cash per share n/a n/a n/a

Size (TTM)

8 measures
MeasureMAVAXP
Market cap $540.9B
98th
$751.7B
100th
$211.8B
95th
Revenue $35.1B
93rd
$44.5B
95th
$84.1B
100th
EBITDA $21.9B
93rd
$29.1B
100th
$24.7B
98th
Net income $16.3B
98th
$22.6B
100th
$11.4B
95th
Free cash flow n/a n/a n/a
Total assets $57.7B
79th
$94.6B
88th
$308.2B
95th
Shareholders' equity $5.6B
79th
$35.2B
95th
$34.3B
93rd
Employees 39,800
95th
34,100
93rd
76,800
98th

Price performance

9 measures
MeasureMAVAXP
1 day +0.2% +0.7% −0.1%
1 week +4.8% +4.5% +1.8%
1 month +9.1% +8.8% +0.8%
3 months +12.8% +11.7% −10.9%
6 months +18.4% +27.0% −5.5%
Year to date +9.8% +16.4% −15.9%
1 year +9.7% +16.7% −5.2%
3 years, cumulative +56.2% +73.7% +111.7%
5 years, cumulative +78.0% +80.5% +88.3%

Technicals

4 measures
MeasureMAVAXP
RSI 14 75.2 73.6 52.4
From 52-week high −0.8% −0.5% −19.1%
From 52-week low +32.9% +37.0% +8.1%
Beta 0.76 0.77 1.08
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms